Yusuf Baran

Prof. Dr. Yusuf Baran is the President of the Izmir Institute of Technology (İYTE) and Chairman of İzmir Technology Development Zone, with concurrent roles on the boards of Bilişim Vadisi AŞ and the Interuniversity Council (ÜAK). His academic career spans professorial positions at İYTE (2008–present) and Abdullah Gul University (2015–2018), focusing on molecular biology and genetics.

His research explores cancer therapeutics, emphasizing leukemia drug resistance, nanomedicine-based drug delivery, and stem cell applications. Key interests include molecular mechanisms of flavonoids (e.g., apigenin, luteolin), miRNA regulation, HER2-targeted nanocarriers, and sphingolipid metabolism in cancer. His work bridges experimental hematology and translational innovation.

Recent publications (2021–2024) highlight trends in overcoming chemoresistance through novel targets (STAT3, non-coding RNAs), advanced drug delivery systems (pH-sensitive micelles), and natural compounds. Articles frequently integrate molecular biology with nanotechnology and metabolism studies.

Awards & Leadership:

• Beni Solow Award (2017)
• Executive roles: Global Young Academy, TWAS, Turkish Academy of Sciences
• Founding member: Biodiversity to Biomedicine Consortium

He leads institutional R&D initiatives and national science policy committees, with no current students or part-time affiliations noted.